Compare TBBK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBBK | LMAT |
|---|---|---|
| Founded | 1999 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.1B |
| IPO Year | 2005 | 2006 |
| Metric | TBBK | LMAT |
|---|---|---|
| Price | $50.58 | $81.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $69.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 565.3K | 205.7K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | 14.69 | ★ 30.57 |
| EPS | ★ 2.86 | 1.42 |
| Revenue | $141,147,000.00 | ★ $249,602,000.00 |
| Revenue This Year | N/A | $14.21 |
| Revenue Next Year | $8.16 | $8.88 |
| P/E Ratio | ★ $17.48 | $56.92 |
| Revenue Growth | ★ 20.85 | 13.53 |
| 52 Week Low | $48.41 | $78.22 |
| 52 Week High | $81.65 | $118.01 |
| Indicator | TBBK | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 28.36 | 49.71 |
| Support Level | N/A | $78.65 |
| Resistance Level | $56.38 | $82.45 |
| Average True Range (ATR) | 1.62 | 1.61 |
| MACD | -0.12 | 0.62 |
| Stochastic Oscillator | 13.03 | 95.63 |
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.